Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting

Clinical trial NCT05633771 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05633771
Sponsor: Sandoz
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Inflammatory Bowel Disease

Start date: 2023-02-16
Primary completion: 2025-12-15
Enrollment: 562

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.